4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-099122
Chief Scientific Officer sold 2,636 shares at an average $45.12 ($118,939)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beskrovnaya Oxana Chief Scientific Officer | 2024-08-19 | Sale 10b5-1 | −2,340 | $45.01 | $105,323 | 145,171 | D |
| Beskrovnaya Oxana Chief Scientific Officer | 2024-08-19 | Sale 10b5-1 | −296 | $46.00 | $13,616 | 144,875 | D |
| Open-market sales · 2,636 sh · avg $45.12 · $118,939 | |||||||
Loading xslF345X05/ownership.xml…